Gene Therapy for Spinal Cord Injury

Gene Therapy of the Central Nervous System: From Bench to Bedside

Volumn , Issue , 2006, Pages 273-288

  Ruitenberg, Marc J ^a,b   Hendriks, William T J ^c   Boer, Gerard J ^c   Verhaagen, Joost ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846112179     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012397632-1/50022-8     Document Type: Chapter

References (166)

1. Agrawal S.K., Fehlings M.G. Mechanisms of secondary injury to spinal cord axons in vitro: role of Na+, Na(+)-K(+)-ATPase, the Na(+)-H+ exchanger, and the Na(+)-Ca2+ exchanger. J. Neurosci. 1996, 16:545-552.
2. Alessandri B., Bullock R. Glutamate and its receptors in the pathophysiology of brain and spinal cord injuries. Prog. Brain Res. 1998, 116:303-330.
3. Akli S., Caillaud C., Vigne E., Stratford-Perricaudet L.D., Poenaru L., Perricaudet M., Kahn A., Peschanski M.R. Transfer of a foreign gene into the brain using adenovirus vectors. Nat. Genet. 1993, 3:224-228.
4. Amar A.P., Levy M.L. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 1999, 44:1027-1039. discussion 1039-1040.
5. Anderson P.N., Campbell G., Zhang Y., Lieberman A.R. Cellular and molecular correlates of the regeneration of adult mammalian CNS axons into peripheral nerve grafts. Prog. Brain Res. 1998, 117:211-232.
6. Bajocchi G., Feldman S.H., Crystal R.G., Mastrangeli A. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nat. Genet. 1993, 3:229-234.
7. Balentine J.D., Spector M. Calcification of axons in experimental spinal cord trauma. Ann. Neurol. 1977, 2:520-523.
8. Bamber N.I., Li H., Lu X., Oudega M., Aebischer P., Xu X.M. Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels. Eur. J. Neurosci. 2001, 13:257-268.
9. Banik N.L., Hogan E.L., Hsu C.Y. The multimolecular cascade of spinal cord injury. Studies on prostanoids, calcium, and proteinases. Neurochem. Pathol. 1987, 7:57-77.
10. Bartholdi D., Schwab M.E. Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat. Brain Res. 1995, 672:177-186.
11. Bartholdi D., Schwab M.E. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur. J. Neurosci. 1997, 9:1422-1438.
12. Baumgartner B.J., Shine H.D. Neuroprotection of spinal motoneurons following targeted transduction with an adenoviral vector carrying the gene for glial cell line-derived neurotrophic factor. Exp. Neurol. 1998, 153:102-112.
13. Blesch A., Conner J.M., Tuszynski M.H. Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression. Gene Ther. 2001, 8:954-960.
14. Blits B. Cell and gene therapy experimental strategies for spinal cord regeneration. Thesis 2002, 175p, Vrije Universiteit Amsterdam.
15. Blits B., Boer G.J., Verhaagen J. Pharmacological, cell, and gene therapy strategies to promote spinal cord regeneration. Cell Transplant. 2002, 11:593-613.
16. Blits B., Carlstedt T.P., Ruitenberg M.J., De Winter F., Hermens W.T., Dijkhuizen P.A., Claassens J.W., Eggers R., Van Der Sluis R., Tenenbaum L., Boer G.J., Verhaagen J. Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor. Exp. Neurol. 2004, 189:303-316.
17. Blits B., Dijkhuizen P.A., Boer G.J., Verhaagen J. Intercostal nerve implants transduced with an adenoviral vector encoding neurotrophin-3 promote regrowth of injured rat corticospinal tract fibers and improve hind limb function. Exp. Neurol. 2000, 164:25-37.
18. Blits B., Dijkhuizen P.A., Carlstedt T.P., Poldervaart H., Schiemanck S., Boer G.J., Verhaagen J. Adenoviral vector-mediated expression of a foreign gene in peripheral nerve tissue bridges implanted in the injured peripheral and central nervous system. Exp. Neurol. 1999, 160:256-267.
19. Blits B., Oudega M., Boer G.J., Bartlett-Bunge M., Verhaagen J. Adeno-associated viral vector-mediated neurotrophin gene transfer in the injured adult rat spinal cord improves hind-limb function. Neuroscience 2003, 118:271-281.
20. Blumer C.E., Quine S. Prevalence of spinal cord injury: an international comparison. Neuroepidemiology 1995, 14:258-268.
21. Bonilla I.E., Tanabe K., Strittmatter S.M. Small prolinerich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth. J. Neurosci. 2002, 22:1303-1315.
22. Boruch A.V., Conners J.J., Pipitone M., Deadwyler G., Storer P.D., Devries G.H., Jones K.J. Neurotrophic and migratory properties of an olfactory ensheathing cell line. Glia 2001, 33:225-229.
23. Bracken M.B. Steroids for acute spinal cord injury. Cochrane Database Syst. Rev. 2002, CD001046.
24. Bracken M.B., Holford T.R. Neurological and functional status 1 year after acute spinal cord injury: estimates of functional recovery in National Acute Spinal Cord Injury Study II from results modelled in National Acute Spinal Cord Injury Study III. J. Neurosurg. 2002, 96:259-266.
25. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002, 416:636-640.
26. Braughler J.M., Hall E.D. Involvement of lipid peroxidation in CNS injury. J. Neurotrauma 1992, 9(Suppl 1):S1-S7.
27. Bregman B.S., Reier P.J. Neural tissue transplants rescue axotomized rubrospinal cells from retrograde death. J. Comp. Neurol. 1986, 244:86-95.
28. Bregman B.S., McAtee M., Dai H.N., Kuhn P.L. Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat. Exp. Neurol. 1997, 148:475-494.
29. Brewer K.L., Bethea J.R., Yezierski R.P. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Exp. Neurol. 1999, 159:484-493.
30. Byrnes A.P., MacLaren R.E., Charlton H.M. Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. J. Neurosci. 1996, 16:3045-3055.
31. Byrnes A.P., Rusby J.E., Wood M.J., Charlton H.M. Adenovirus gene transfer causes inflammation in the brain. Neuroscience 1995, 66:1015-1024.
32. Cao L., Liu L., Chen Z.Y., Wang L.M., Ye J.L., Qiu H.Y., Lu C.L., He C. Olfactory ensheathing cells genetically modified to secrete GDNF to promote spinal cord repair. Brain 2004, 127:535-549.
33. Carlson S.L., Parrish M.E., Springer J.E., Doty K., Dossett L. Acute inflammatory response in spinal cord following impact injury. Exp. Neurol. 1998, 151:77-88.
34. Castellanos D.A., Tsoulfas P., Frydel B.R., Gajavelli S., Bes J.C., Sagen J. TrkC overexpression enhances survival and migration of neural stem cell transplants in the rat spinal cord. Cell. Transplant. 2002, 11:297-307.
35. Cheng H., Cao Y., Olson L. Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function. Science 1996, 273:510-513.
36. Choi D.W. Excitotoxic cell death. J. Neurobiol. 1992, 23:1261-1276.
37. Costigan M., Befort K., Karchewski L., Griffin R.S., D'Urso D., Allchorne A., Sitarski J., Mannion J.W., Pratt R.E., Woolf C.J. Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury. BMC Neurosci. 2002, 3:16.
38. Crowe M.J., Bresnahan J.C., Shuman S.L., Masters J.N., Beattie M.S. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 1997, 3:73-76.
39. David S., Aguayo A.J. Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science 1981, 214:931-933.
40. Davidson B.L., Allen E.D., Kozarsky K.F., Wilson J.M., Roessler B.J. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat. Genet. 1993, 3:219-223.
41. De Winter F., Oudega M., Lankhorst A.J., Hamers F.P., Blits B., Ruitenberg M.J., Pasterkamp R.J., Gispen W.H., Verhaagen J. Injury-induced class 3 semaphorin expression in the rat spinal cord. Exp. Neurol. 2002, 175:61-75.
42. Dijkhuizen P.A., Hermens W.T., Teunis M.A., Verhaagen J. Adenoviral vector-directed expression of neurotrophin-3 in rat dorsal root ganglion explants results in a robust neurite outgrowht response. J. Neurobiol. 1997, 33:172-184.
43. Dijkhuizen P.A., Pasterkamp R.J., Hermens W.T., de Winter F., Giger R.J., Verhaagen J. Adenoviral vector-mediated gene delivery to injured rat peripheral nerve. J. Neurotrauma 1998, 15:387-397.
44. Faden A.I., Simon R.P. A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann. Neurol. 1988, 23:623-626.
45. Fawcett J.W., Asher R.A. The glial scar and central nervous system repair. Brain Res. Bull. 1999, 49:377-391.
46. FederoffH.J., Geschwind M.D., Geller A.I., Kessler J.A. Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. Proc. Natl. Acad. Sci. USA 1992, 89:1636-1640.
47. Feldblum S., Arnaud S., Simon M., Rabin O., D'Arbigny P. Efficacy of a new neuroprotective agent, gacyclidine, in a model of rat spinal cord injury. J. Neurotrauma 2000, 17:1079-1093.
48. Fouad K., Dietz V., Schwab M.E. Improving axonal growth and functional recovery after experimental spinal cord injury by neutralizing myelin associated inhibitors. Brain Res. Rev. 2001, 36:204-212.
49. Gaviria M., Privat A., d'Arbigny P., Kamenka J.M., Haton H., Ohanna F. Neuroprotective effects of gacyclidine after experimental photochemical spinal cord lesion in adult rats: dose-window and time-window effects. J. Neurotrauma 2000, 17:19-30.
50. Gaviria M., Privat A., d'Arbigny P., Kamenka J., Haton H., Ohanna F. Neuroprotective effects of a novel NMDA antagonist, Gacyclidine, after experimental contusive spinal cord injury in adult rats. Brain Res. 2000, 874:200-209.
51. Gravel C., Gotz R., Lorrain A., Sendtner M. Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons. Nat. Med. 1997, 3:765-770.
52. Grill R., Murai K., Blesch A., Gage F.H., Tuszynski M.H. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J. Neurosci. 1997, 17:5560-5572.
53. Grill R.J., Blesch A., Tuszynski M.H. Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells. Exp. Neurol. 1997, 148:444-452.
54. Gruner J.A. A monitored contusion model of spinal cord injury in the rat. J. Neurotrauma 1992, 9:123-126. discussion 126-128.
55. Haghighi S.S., Agrawal S.K., Surdell D., Plambeck R., Agrawal S., Johnson G.C., Walker A. Effects of methylprednisolone and MK-801 on functional recovery after experimental chronic spinal cord injury. Spinal Cord 2000, 38:733-740.
56. Haghighi S.S., Johnson G.C., de Vergel C.F., Vergel Rivas B.J. Pretreatment with NMDA receptor antagonist MK801 improves neurophysiological outcome after an acute spinal cord injury. Neurol. Res. 1996, 18:509-515.
57. Hall E.D. Pharmacological treatment of acute spinal cord injury: how do we build on past success?. J. Spinal Cord Med. 2001, 24:142-146.
58. Hall E.D., Braughler J.M. Effects of intravenous methyl-prednisolone on spinal cord lipid peroxidation and Na+ +K+-ATPase activity. Dose-response analysis during 1st hour after contusion injury in the cat. J. Neurosurg. 1982, 57:247-253.
59. Hermann G.E., Rogers R.C., Bresnahan J.C., Beattie M.S. Tumor necrosis factor-alpha induces cFOS and strongly potentiates glutamate-mediated cell death in the rat spinal cord. Neurobiol. Dis. 2001, 8:590-599.
60. Hermanns S., Klapka N., Muller H.W. The collagenous lesion scar-an obstacle for axonal regeneration in brain and spinal cord injury. Restor. Neurol. Neurosci. 2001, 19:139-148.
61. Hermens W.T., Giger R.J., Holtmaat A.J., Dijkhuizen P.A., Houweling D.A., Verhaagen J. Transient gene transfer to neurons and glia: analysis of adenoviral vector performance in the CNS and PNS. J. Neurosci. Methods. 1997, 71:85-98.
62. Hermens W.T., Verhaagen J. Viral vectors, tools for gene transfer in the nervous system. Prog. Neurobiol. 1998, 55:399-432.
63. Huber A.B., Ehrengruber M.U., Schwab M.E., Brosamle C. Adenoviral gene transfer to the injured spinal cord of the adult rat. Eur. J. Neurosci. 2000, 12:3437-3442.
64. Hurlbert R.J. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J. Neurosurg. 2000, 93:1-7.
65. Ide C. Peripheral nerve regeneration. Neurosci. Res. 1996, 25:101-121.
66. Iizuka H., Yamamoto H., Iwasaki Y., Yamamoto T., Konno H. Evolution of tissue damage in compressive spinal cord injury in rats. J. Neurosurg. 1987, 66:595-603.
67. Jimenez C.R., Stam F.J., Li K.W., Gouwenberg Y., Hornshaw M.P., De Winter F., Verhaagen J., Smit A.B. Proteomics of the injured rat sciatic nerve reveals protein expression dynamics during regeneration. Mol. Cell Proteomics 2005, 4:120-132.
68. Jones N., Shenk T. An adenovirus type 5 early gene function regulates expression of other early viral genes. Proc. Natl. Acad. Sci. USA 1979, 76:3665-3669.
69. Kajiwara K., Bymes A.P., Charlton H.H., Wood M.J., Wood K.J. Immune responses to adenoviral vectors during gene transfer in the brain. Hum. Gene Ther. 1997, 8:253-265.
70. Kaplitt M.G., Leone P., Samulski R.J., Xiao X., PfaffD.W., O'Malley K.L., During M.J. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 1994, 8:148-154.
71. Kaplitt M.G., Pfaus J.G., Kleopoulos S.P., Hanlon B.A., Rabkin S.D., PfaffD.W. Expression of a functional foreign gene in adult mammalian brain following in vivo transfer via a herpes simplex virus type 1 defective viral vector. Mol. Cell. Neurosci. 1991, 2:320-330.
72. Keir S.D., Mitchell W.J., Feldman L.T., Martin J.R. Targeting and gene expression in spinal cord motor neurons following intramuscular inoculation of an HSV-1 vector. J. Neurovirol. 1995, 1:259-267.
73. Kennedy P.G. Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders. Brain 1997, 120:1245-1259.
74. Kim D.H., Gutin P.H., Noble L.J., Nathan D., Yu J.S., Nockels R.P. Treatment with genetically engineered fibroblasts producing NGF or BDNF can accelerate recovery from traumatic spinal cord injury in the adult rat. Neuroreport 1996, 7:2221-2225.
75. Kim D., Schallert T., Liu Y., Browarak T., Nayeri N., Tessler A., Fischer I., Murray M. Transplantation of genetically modified fibroblasts expressing BDNF in adult rats with a subtotal hemisection improves specific motor and sensory functions. Neurorehab. Neural Re. 2001, 15:141-150.
76. Klusman I., Schwab M.E. Effects of pro-inflammatory cytokines in experimental spinal cord injury. Brain Res. 1997, 762:173-184.
77. Koshinaga M., Whittemore S.R. The temporal and spatial activation of microglia in fiber tracts undergoing anterograde and retrograde degeneration following spinal cord lesion. J. Neurotrauma 1995, 12:209-222.
78. Krikorian J.G., Guth L., Donati E.J. Origin of the connective tissue scar in the transected rat spinal cord. Exp. Neurol. 1981, 72:698-707.
79. Kwon B.K., Oxland T.R., TetzlaffW. Animal models used in spinal cord regeneration research. Spine 2002, 27:1504-1510.
80. Lakatos A., Barnett S.C., Franklin R.J. Olfactory ensheathing cells induce less host astrocyte response and chondroitin sulphate proteoglycan expression than Schwann cells following transplantation into adult CNS white matter. Exp. Neurol. 2003, 184:237-246.
81. Lacroix S., Tuszynski M.H. Neurotrophic factors and gene therapy in spinal cord injury. Neurorehab. Neural Re. 2000, 14:265-275.
82. Lakatos A., Franklin R.J., Barnett S.C. Olfactory ensheathing cells and Schwann cells differ in their in vitro interactions with astrocytes. Glia 2000, 32:214-225.
83. Lee Y.B., Yune T.Y., Baik S.Y., Shin Y.H., Du S., Rhim H., Lee E.B., Kim Y.C., Shin M.L., Markelonis G.J., Oh T.H. Role of tumor necrosis factor-alpha in neuronal and glial apoptosis after spinal cord injury. Exp. Neurol. 2000, 166:190-195.
84. Le Gal La Salle G., Robert J.J., Berrard S., Ridoux V., Stratford-Perricaudet L.D., Perricaudet M., Mallet J. An adeno-virus vector for gene transfer into neurons and glia in the brain. Science 1993, 259:988-990.
85. Leib D.A., Olivo P.D. Gene delivery to neurons: is herpes simplex virus the right tool for the job?. Bioessays 1993, 15:547-554.
86. Leskovar A., Moriarty L.J., Turek J.J., Schoenlein I.A., Borgens R.B. The macrophage in acute neural injury: changes in cell numbers over time and levels of cytokine production in mammalian central and peripheral nervous systems. J. Exp. Biol. 2000, 203:1783-1795.
87. Levi A.D., Tator C.H., Bunge R.P. Clinical syndromes associated with disproportionate weakness of the upper versus the lower extremities after cervical spinal cord injury. Neurosurgery 1996, 38:179-183. discussion 183-175.
88. Leybaert L., De Hemptinne A. Changes of intracellular free calcium following mechanical injury in a spinal cord slice preparation. Exp. Brain Res. 1996, 112:392-402.
89. Li Y., Field P.M., Raisman G. Repair of adult rat cortico-spinal tract by transplants of olfactory ensheathing cells. Science 1997, 277:2000-2002.
90. Li Y., Field P.M., Raisman G. Regeneration of adult rat corticospinal axons induced by transplanted olfactory ensheathing cells. J. Neurosci. 1998, 18:10514-10524.
91. Lilley C.E., Groutsi F., Han Z., Palmer J.A., Anderson P.N., Latchman D.S., Coffin R.S. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo. J. Virol. 2001, 75:4343-4356.
92. Liu Y., Himes B.T., Murray M., Tessler A., Fischer I. Grafts of BDNF-producing fibroblasts rescue axotomized rubrospinal neurons and prevent their atrophy. Exp. Neurol. 2002, 178:150-164.
93. Liu Y., Himes B.T., Solowska J., Moul J., Chow S.Y., Park K.I., Tessler A., Murray M., Snyder E.Y., Fischer I. Intraspinal delivery of neurotrophin-3 using neural stem cells genetically modified by recombinant retrovirus. Exp. Neurol. 1999, 158:9-26.
94. Liu Y., Himes B.T., Tryon B., Moul J., Chow S.Y., Jin H., Murray M., Tessler A., Fischer I. Intraspinal grafting of fibroblasts genetically modified by recombinant adenoviruses. Neuroreport 1998, 9:1075-1079.
95. Liu Y., Kim D., Himes B.T., Chow S.Y., Schallert T., Murray M., Tessler A., Fischer I. Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J. Neurosci. 1999, 19:4370-4387.
96. Liu D., Thangnipon W., McAdoo D.J. Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord. Brain Res. 1991, 547:344-348.
97. Liu S., Qu Y., Stewart T.J., Howard M.J., Chakrabortty S., Holekamp T.F., McDonald J.W. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc. Natl. Acad. Sci. USA 2000, 97:6126-6131.
98. Liu X.Z., Xu X.M., Hu R., Du C., Zhang S.X., McDonald J.W., Dong H.X., Wu Y.J., Fan G.S., Jacquin M.F., Hsu C.Y., Choi D.W. Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 1997, 17:5395-5406.
99. Mata M., Zhang M., Hu X., Fink D.J. HveC (nectin-1) is expressed at high levels in sensory neurons but not in motor neurons, of the rat peripheral nervous system. J. Neurovirol. 2001, 7:476-480.
100. Matthews M.A., St Onge M.F., Faciane C.L. An electron microscopic analysis of abnormal ependymal cell proliferation and envelopment, of sprouting axons following spinal cord transection in the rat. Acta. Neuropathol. (Berl.) 1979, 45:27-36.
101. McDonald J.W. Repairing the damaged spinal cord. Sci. Am. 1999, 281:64-73.
102. McDonald J.W., Liu X.Z., Qu Y., Liu S., Mickey S.K., Turetsky D., Gottlieb D.I., Choi D.W. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat. Med. 1999, 5:1410-1412.
103. McDonald J.W., Sadowsky C. Spinal-cord injury. Lancet 2002, 359:417-425.
104. McTigue D.M., Horner P.J., Stokes B.T., Gage F.H. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused, adult rat spinal cord. J. Neurosci. 1998, 18:5354-5365.
105. Menei P., Montero-Menei C., Whittemore S.R., Bunge R.P., Bunge M.B. Schwann cells genetically modified to secrete human BDNF promote enhanced axonal regrowth across transsected adult rat spinal cord. Eur. J. Neurosci. 1998, 10:607-621.
106. Metz G.A., Curt A., van de Meent H., Klusman I., Schwab M.E., Dietz V. Validation of the weight-drop contusion model in rats: a comparative study of human spinal cord injury. J. Neurotrauma 2000, 17:1-17.
107. Mu A., Azbill R.D., Springer J.E. NBQX treatment improves mitochondrial function and reduces oxidative events after spinal cord injury. J. Neurotrauma 2002, 19:917-927.
108. Muir G.D., Webb A.A. Mini-review: assessment of behavioural recovery following spinal cord injury in rats. Eur. J. Neurosci. 2000, 12:3079-3086.
109. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996, 272:263-267.
110. Nathan P.W. Effects on movement of surgical incisions into the human spinal cord. Brain 1994, 117:337-346.
111. Natsume A., Mata M., Wolfe D., Oligino T., Goss J., Huang S., Glorioso J., Fink J. Bcl-2 and GDNF delivered by HSV-mediated gene transfer spinal root avulsion provide a synergistic effect. J. Neurotrauma 2002, 19:61-68.
112. Nesic O., Xu G.Y., McAdoo D., High K.W., Hulsebosch C., Perez-Pol R. IL-1 receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury. J. Neurotrauma 2001, 18:947-956.
113. Nevins J.R. Mechanism of activation of early viral transcription by the adenovirus E1A gene product. Cell 1981, 26:213-220.
114. Niclou S.P., Ehlert E.M., Verhaagen J. Chemorepellent axon guidance molecules in spinal cord injury. J. Neurotrauma 2005, In press.
115. Oudega M., Vargas C.G., Weber A.B., Kleitman N., Bunge M.B. Long-term effects of methylprednisolone following transection of adult rat spinal cord. Eur. J. Neurosci. 1999, 11:2453-2464.
116. Panter S.S., Yum S.W., Faden A.I. Alteration in extracellular amino acids after traumatic spinal cord injury. Ann. Neurol. 1990, 27:96-99.
117. Pasterkamp R.J., Verhaagen J. Emerging roles for semaphorins in neural regeneration. Brain. Res. Rev. 2001, 35:36-54.
118. Pasterkamp R.J., Anderson P.N., Verhaagen J. Peripheral nerve injury fails to induce growth of lesioned ascending dorsal column axons into spinal cord scar tissue expressing the axon repellent Semaphorin3A. Eur. J. Neurosci. 2001, 13:457-471.
119. Pasterkamp R.J., Giger R.J., Ruitenberg M.J., Holtmaat A.J., De Wit J., De Winter F., Verhaagen J. Expression of the gene encoding the chemorepellent semaphorin III is induced in the fibroblast component of neural scar tissue formed following injuries of adult but not neonatal CNS. Mol. Cell. Neurosci. 1999, 13:143-166.
120. Peel A.L., Zolotukhin S., Schrimsher G.W., Muzyczka N., Reier P.J. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene. Ther. 1997, 4:16-24.
121. Popovich P.G., Streit W.J., Stokes B.T. Differential expression of MHC class II antigen in the contused rat spinal cord. J. Neurotrauma 1993, 10:37-46.
122. Plant G.W., Bates M.L., Bunge M.B. Inhibitory, proteoglycan immunoreactivity is higher at the caudal than the rostral Schwann, cell graft-transected spinal cord interface. Mol. Cell. Neurosci. 2001, 17:471-487.
123. Ramon-Cueto A., Cordero M.I., Santos-Benito F.F., Avila J. Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 2000, 25:425-435.
124. Ramon-Cueto A., Nieto-Sampedro M. Regeneration into the spinal cord of transected dorsal root axons is promoted by ensheathing glia transplants. Exp. Neurol. 1994, 127:232-244.
125. Ramon-Cueto A., Plant G.W., Avila J., Bunge M.B. Long-distance axonal regneration in the transected adult rat spinal cord is promoted by olfactory, ensheathing glia transplants. J. Neurosci. 1998, 18:3803-3815.
126. Richardson P.M., McGuinness U.M., Aguayo A.J. Axons from CNS neurons regenerate into PNS grafts. Nature 1980, 284:264-265.
127. Romero M.I., Rangappa N., Garry M.G., Smith G.M. Functional regeneration of chronically injured sensory afferents into adult spinal cord after neurotrophin gene therapy. J. Neurosci. 2001, 21:8408-8416.
128. Romero M.I., Rangappa N., Li L., Lightfoot E., Garry M.G., Smith G.M. Extensive sprouting of sensory afferents and hyperalgesia induced by conditional expression of nerve growth factor in the adult spinal cord. J. Neurosci. 2000, 20:4435-4445.
129. Ruitenberg M.J., Blits B., Dijkhuizen P.A., te Beek E.T., Bakker A., van Heerikhuize J.J., Pool C.W., Hermens W.T., Boer G.J., Verhaagen J. Adeno-associated viral vector-mediated gene transfer of brain-derived neurotrophic factor reverses atrophy of rubrospinal neurons following both acute and chronic spinal cord injury. Neurobiol. Dis. 2004, 15:394-406.
130. Ruitenberg M.J., Eggers R., Boer G.J., Verhaagen J. Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system. Methods 2002, 28:182-194. Review.
131. Ruitenberg M.J., Levison D.B., Lee S.V., Verhaagen J., Harvey A.R., Plant G.W. NT-3 expression from engineered olfactory ensheathing glia promotes spinal sparing and regeneration. Brain 2005, 128:839-853.
132. Ruitenberg M.J., Plant G.W., Christensen C.L., Blits B., Niclou S.P., Harvey A.R., Boer G.J., Verhaagen J. Viral vector-mediated gene expression in olfactory ensheathing glia implants in the lesioned rat spinal cord. Gene Ther. 2002, 9:135-146.
133. Ruitenberg M.J., Plant G.w., Hamers F.P., Wortel J., Blits B., Dijkhuizen P.A., Gispen W.H., Boer G.J., Verhaagen J. Ex vivo adenoviral vector-mediated neurotrophin gene transfer to olfactory ensheathing glia: effects on rubrospinal tract regeneration, lesion size, and functional recovery after implantation in the injured rat spinal cord. J. Neurosci. 2003, 23:7045-7058.
134. Schwab M.E., Bartholdi D. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol. Rev. 1996, 76:319-370.
135. Shearer M.C., Fawcett J.W. The astrocyte/meningeal cell interface-a barrier to successful nerve regeneration?. Cell Tissue Res. 2001, 305:267-273.
136. Shuman S.L., Bresnahan J.C., Beattie M.S. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J. Neurosci. Res. 1997, 50:798-808.
137. Smith G.M., Hale J., Pasnikowski E.M., Lindsay R.M., Wong V., Rudge J.S. Astrocytes infected with replication-defective adenovirus containing a secreted form of CNTF of NT3 show enhanced support of neuronal populations in vitro. Exp. Neurol. 1996, 139:156-166.
138. Snyder E.Y., Senut M.C. The use of nonneuronal cells for gene delivery. Neurobiol. Dis. 1997, 4:69-102.
139. Steward O., Zheng B., Tessier-Lavigne M. False resurrections: distinguishing regenerated from spared axons in the injured central nervous system. J. Comp. Neurol. 2003, 459:1-8.
140. Stichel C.C., Hermans S., Luhmann H.J., Lausberg F., Niermann H., D'Urso D., Servos G., Hartwig H.G., Muller H.W. Inhibition of collagen IV deposition promotes regeneration of injured CNS axons. Eur. J. Neurosci. 1999, 11:632-646.
141. Streit W.J., Semple-Rowland S.L., Hurley S.D., Miller R.C., Popovich P.G., Stokes B.T. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp. Neurol. 1998, 152:74-87.
142. Teng Y.D., Lavik E.B., Qu X., Park K.I., Ourednik J., Zurakowski D., Langer R., Snyder E.Y. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc. Natl. Acad. Sci. USA 2002, 99:3024-3029.
143. Tang X.Q., Tanelian D.L., Smith G.M. Semaphorin3A inhibits nerve growth factor-induced sprouting of nociceptive afferents in adult rat spinal cord. J. Neurosci. 2004, 24:819-827.
144. Tator C.H., Fehlings M.G. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 1991, 75:15-26.
145. Terada H., Kazui T., Takinami M., Yamashita K., Washiyama N., Muhammad B.A. Reduction of ischemic spinal cord injury by dextrorphan: comparison of several methods of administration. J. Thorac. Cardiovasc. Surg. 2001, 122:979-985.
146. Topsakal C., Erol F.S., Ozveren M.F., Yilmaz N., Ilhan N. Effects of methylprednisolone and dextromethorphan on lipid peroxidation in an experimental model of spinal cord injury. Neurosurg. Rev. 2002, 25:258-266.
147. Tuszynski M.H., Gabriel K., Gage F.H., Suhr S., Meyer S., Rosetti A. Nerve growth factor delivery by gene transfer induces differential outgrowth of sensory, motor, and noradrenergic neurites after adult spinal cord injury. Exp. Neurol. 1996, 137:157-173.
148. Tuszynski M.H., Murai K., Blesch A., Grill R., Miller I. Functional characterization of NGF-secreting cell grafts to the acutely injured spinal cord. Cell Transplant. 1997, 6:361-368.
149. Tuszynski M.H., Peterson D.A., Ray J., Baird A., Nakahara Y., Gage F.H. Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord. Exp. Neurol. 1994, 126:1-14.
150. Tuszynski M.H., Weidner N., McCormack M., Miller I., Powell H., Conner J. Grafts of genetically modified Schwann cells to the spinal cord: survival, axon growth, and myelination. Cell Transplant. 1998, 7:187-196.
151. Van Asbeck F.W., Post M.W., Pangalila R.F. An epidemiological description of spinal cord injuries in The Netherlands in 1994. Spinal Cord 2000, 38:420-424.
152. Vercelli A., Repici M., Garbossa D., Grimaldi A. Recent techniques for tracing pathways in the central nervous system of developing and adult mammals. Brain Res. Bull. 2000, 51:11-28.
153. Wada S., Yone K., Ishidou Y., Nagamine T., Nakahara S., Niiyama T., Sakou T. Apoptosis following spinal cord injury in rats and preventative effect of N-methyl-d-aspartate receptor antagonist. J. Neurosurg. 1999, 91:98-104.
154. Watanabe T., Yamamoto T., Abe Y., Saito N., Kumagai T., Kayama H. Differential activation of microglia after experimental spinal cord injury. J. Neurotrauma 1999, 16:255-265.
155. Weidner N., Blesch A., Grill R.J., Tuszynski M.H. Nerve grwoth factor-hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate manner that correlates with expression of L1. J. Comp. Neurol. 1999, 413:495-506.
156. Williams S.K., Frankin R.J., Bernett S.C. Response of olfactory ensheeting cells to the degeneration and regeneration of the peripheral olfactory system and the involvement of the neuroregulins. J. Comp. Neurol. 2004, 470:50-62.
157. Wood M.J., Byrnes A.P., PfaffD.W., Rabkin S.D., Charlton H.M. Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. Gene. Ther. 1994, 1:283-291.
158. Wood M.J., Byrnes A.P., Rabkin S.D., PfaffD.W., Charlton H.M. Immunological consequences of HSV-1-mediated gene transfer into the CNS. Gene. Ther. 1994, 1(Suppl. 1):S82.
159. Wood M.J., Charlton H.M., Wood K.J., Kajiwara K., Byrnes A.P. Immune responses to adenovirus vectors in the nervous system. Trends Neurosci. 1996, 19:497-501.
160. Xu J., Fan G., Chen S., Wu Y., Xu X.M., Hsu C.Y. Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats. Brain Res. Mol. Rrain Res. 1998, 59:135-142.
161. Xu X.M., Guenard V., Kleitman N., Aebischer P., Bunge M.B. A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp. Neurol 1995, 134:261-272.
162. Yamada M., Natsume A., Mata M., Oligino T., Goss J., Glorioso J., Fink D.J. Herpes simplex virus vector-mediated expression of Bcl-2 protects spinal motor neurons from degeneration following root avulsion. Exp. Neurol. 2001, 168:225-230.
163. Young W. Role of calcium in central nervous system injuries. J. Neurotrauma 1992, 9(Suppl. 1):S9-S25.
164. Zhang Y., Dijkhuizen P.A., Anderson P.N., Lieberman A.R., Verhaagen J. NT-3 delivered by an adenoviral vector induces injured dorsal root axons to regenerate into the spinal cord of adult rats. J. Neurosci. Res. 1998, 54:554-562.
165. Zhang Y., Schneider R.J. Adenovirus inhibition of cell translation facilitates release of virus particles and enhances degradation of the cytokeratin network. J. Virol. 1994, 68:2544-2555.
166. Zhou L., Baumgartner B.J., Hill-Felberg S.J., McGowen L.R., Shine H.D. Neurotrophin-3 expressed in situ induces axonal plasticity in the adult injured spinal cord. J. Neurosci. 2003, 23:1424-1431.